Stay updated on Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Recruitment status now indicates no further participant recruitment; new help sections were added to assist users in reading, understanding, and joining studies, along with minor label formatting changes and a revision tag.
    Difference
    0.5%
    Check dated 2026-06-12T16:46:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.5, replacing v3.5.4. This represents a small internal update to the page's revision history and does not change the displayed study information.
    Difference
    0.1%
    Check dated 2026-06-05T15:39:35.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.4), replacing the previous v3.5.3. This update reflects a new page revision in the metadata and does not change the underlying study content.
    Difference
    0.1%
    Check dated 2026-05-15T05:55:15.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3. This reflects a tooling/version update without indicating changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:08:24.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:27.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added 'B-cell chronic lymphocytic leukemia' as a disease keyword on the Study Details page.
    Difference
    0.1%
    Check dated 2026-04-02T15:37:29.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.